Peer-reviewed journal articles (24)
  1. 1. Huet, S., Zeisser Labouebe, M., Castro, R., Jacquot, P., Pedrault, J., Viollet, S., Van Simaeys, G., Doumont, G., Larbanoix, L., Zindy, E., Cunha, A. E., Scapozza, L., & Cinier, M. (2023). Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model. Molecular cancer therapeutics, 22(11), 1343-1351. doi:10.1158/1535-7163.MCT-22-0805
  2. 2. Lavis, P., Pingitore, J., Doumont, G., Garabet, A., Van Simaeys, G., Lacroix, S., Passon, N., Van Heymbeek, C., De Maeseneire, C., Allard, J., Collin, A., Huaux, F., Decaestecker, C., Salmon, I., Goldman, S., Cardozo, A. K., & Bondue, B. (2023). Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis. Respiratory research, 24(1), 254. doi:10.1186/s12931-023-02556-6
  3. 3. Romitti, M., Tourneur, A., De Faria Da Fonseca, B., Doumont, G., Gillotay, P., Liao, X. H., Eski, S. E., Van Simaeys, G., Chomette, L., Lasolle, H., Monestier, O., Figini Kasprzyk, D., Detours, V., Singh, S. P., Goldman, S., Refetoff, S., & Costagliola, S. (2022). Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism. Nature communications, 13(1). doi:10.1038/s41467-022-34776-7
  4. 4. Vila, I., Chamma, H., Steer, A., Saccas, M., Taffoni, C., Turtoi, E., Reinert, L. S., Hussain, S., Marines, J., Jin, L., Bonnefont, X., Hubert, M., Schwartz, O., Paludan, S. R., Van Simaeys, G., Doumont, G., Sobhian, B., Vlachakis, D., Turtoi, A., & Laguette, N. (2022). STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses. Cell Metabolism, 34(1), 125-139.e8. doi:10.1016/j.cmet.2021.12.007
  5. 5. Lien, V. T., Celen, S., Nuruddin, S., Attili, B., Doumont, G., Van Simaeys, G., Bormans, G., Klaveness, J., & Olberg, D. E. (2021). Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model. Nuclear medicine and biology, 93, 74-80. doi:10.1016/j.nucmedbio.2020.12.002
  6. 6. Rouchota, M., Adamiano, A., Iafisco, M., Fragogeorgi, E., Pilatis, I., Doumont, G., Boutry, S., Catalucci, D., Zacharioudaki, A., & Kagadis, G. G. (2021). Optimization of in Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System. Molecular imaging, 2021, 6677847. doi:10.1155/2021/6677847
  7. 7. Chiavarina, B., Costanza, B., Ronca, R., Blomme, A., Rezzola, S., Chiodelli, P., Giguelay, A., Belthier, G., Doumont, G., Van Simaeys, G., Lacroix, S., Yokobori, T., Erkhem-Ochir, B., Balaguer, P., Cavailles, V., Fabbrizio, E., Di Valentin, E., Gofflot, S., Detry, O., Jerusalem, G., Goldman, S., Delvenne, P. O., Bellahcène, A., Pannequin, J., Castronovo, V., & Turtoi, A. (2021). Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis. Theranostics, 11(4), 1626-1640. doi:10.7150/thno.51507
  8. 8. Van Simaeys, G., Doumont, G., De Maeseneire, C., Passon, N., Lacroix, S., Lentz, C., Horion, A., Warnier, C., Torres, D., Martens, C., Vierasu, I., Egrise, D., & Goldman, S. (2021). [18F]-JK-PSMA-7 and [18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice. European journal of nuclear medicine and molecular imaging. doi:10.1007/s00259-020-05169-z
  9. 9. Bondue, B., Castiaux, A., Van Simaeys, G., Mathey, C., Sherer, F., Egrise, D., Lacroix, S., Huaux, F., Doumont, G., & Goldman, S. (2019). Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients. Respiratory research, 20(1), 10. doi:10.1186/s12931-019-0974-5
  10. 10. Blomme, A., Van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., Lovinfosse, P., Boutry, S., Palacios, A., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcene, A., Delvenne, P. O., Detry, O., Goldman, S., Nishiyama, M., Castronovo, V., & Turtoi, A. (2018). Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene, 37(9), 1237-1250. doi:10.1038/s41388-017-0018-x
  11. 11. Goux, M., Doumont, G., Plenevaux, A., Cinier, M., Luxen, A., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., Lallemand, F., & Bahri, M. A. (2017). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate chemistry, 28(9), 2361-2371. doi:10.1021/acs.bioconjchem.7b00374
  12. 12. Andrianne, M., Assabban, A., La, C., Mogilenko, D., Salle, D. S., Fleury, S., Doumont, G., Van Simaeys, G., Nedospasov, S. A., Blackshear, P. J., Dombrowicz, D., Goriely, S., & Van Maele, L. (2017). Tristetraprolin expression by keratinocytes controls local and systemic inflammation. JCI insight, 2(11). doi:10.1172/jci.insight.92979
  13. 13. Wimana, Z., Ghanem, G. E., Gebhart, G., Guiot, T., Vanderlinden, B., Larsimont, D., Doumont, G., Van Simaeys, G., Goldman, S., & Flamen, P. (2017). N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging. Oncotarget, 8(34), 56185-56198. doi:10.18632/oncotarget.17015
  14. 14. Blomme, A., Costanza, B., de Tullio, P., Thiry, M., Van Simaeys, G., Boutry, S., Doumont, G., Di Valentin, E., Hirano, T., Yokobori, T., Gofflot, S., Peulen, O., Bellahcene, A., Sherer, F., Le Goff, C., Cavalier, E., Mouithys-Mickalad, A., Jouret, F., Cusumano, P. G., Lifrange, E., Muller, R. N., Goldman, S., Delvenne, P., De Pauw, E., Nishiyama, M., Castronovo, V., & Turtoi, A. (2016). Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer. Oncogene. doi:10.1038/onc.2016.369
  15. 15. Langhendries, J.-L., Nicolas, E., Doumont, G., Goldman, S., & Lafontaine, D. (2016). The human box C/D snoRNAs U3 and U8 are required for prerRNA processing and tumorigenesis. Oncotarget, 7(37), 59519-59534. doi:10.18632/oncotarget.11148
  16. 16. Wimana, Z., Gebhart, G., Guiot, T., Vanderlinden, B., Morandini, R., Doumont, G., Sherer, F., Van Simaeys, G., Goldman, S., Ghanem, G. E., & Flamen, P. (2015). Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model. Molecular imaging and biology. doi:10.1007/s11307-015-0840-x
  17. 17. Bondue, B., Sherer, F., Van Simaeys, G., Doumont, G., Egrise, D., Yakoub, Y., Huaux, F., Parmentier, M., Rorive, S., Sauvage, S., Lacroix, S., Vosters, O., De Vuyst, P., & Goldman, S. (2015). PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis. The Journal of nuclear medicine, 56(1), 127-132. doi:10.2967/jnumed.114.147421
  18. 18. Lacroix, S., Egrise, D., Van Simaeys, G., Doumont, G., Monclus, M., Sherer, F., Herbaux, T., Leroy, D., & Goldman, S. (2013). [18F]-FBEM, a tracer targeting cell-surface protein thiols for cell trafficking imaging. Contrast Media & Molecular Imaging, 8(5), 409-416. doi:10.1002/cmmi.1540
  19. 19. Doumont, G., De Visser, K. E., Derksen, P. W. B., & Jonkers, J. (2008). Models for angiogenesis: From fundamental mechanisms to anticancer treatment research. Drug Discovery Today: Disease Models, 4(2), 75-82. doi:10.1016/j.ddmod.2007.12.001
  20. 20. Maetens, M. M., Doumont, G., De Clercq, S., Francoz, S., Froment, P., Bellefroid, E., Klingmuller, U., Lozano, G., & Marine, J.-C. (2007). Distinct roles of Mdm2 and Mdm4 in red cell production. Blood, 109(6), 2630-2633.
    21. << Previous 1 2 Next >>